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Abstract: This study aimed to investigate the associations of competitive sport participation in
adolescence and age at menarche (AAM) with body composition, femoral neck bone mineral density
(BMD), physical performance, and physical activity (PA) in middle-aged women. 1098 women aged
47–55 years formed the sample of this retrospective study. Participants self-reported their PA level at
age 13–16 years and AAM. The protocol also included dual-energy X-ray absorptiometry, physical
performance tests, and accelerometer-measured PA. Participants were divided into three groups
according to their PA level at the age of 13–16 (no exercise, regular PA, and competitive sport) and
according to their AAM (≤12, 13, and ≥14 years). After adjusting for potential confounding factors,
participation in competitive sport at age 13–16 was associated with higher midlife lean mass and BMD,
and better physical performance compared to groups with no exercise or regular PA. Individuals
with AAM ≥ 14 years had lower midlife BMI and fat mass than participants in the other AAM
groups and pre- and perimenopausal women with AAM ≥ 14 years had lower BMD than those with
AAM ≤ 12. The findings indicate that participation in competitive sport in adolescence is associated
with healthier body composition, higher BMD, and better physical performance in midlife, but BMD
might be impaired if menarche occurs late.
Keywords: adolescent athlete; female athlete; age at menarche; body composition; bone mineral
density; physical performance; physical activity
1. Introduction
Physical activity (PA) provides many health benefits, especially during adolescence [1].
Adolescence is a critical time for skeletal growth and mineralization [2], which is enhanced with
weight-bearing PA [3]. Studies with female participants have shown that sport participation in
childhood/adolescence is associated with better bone health in early [4–6] and late adulthood [7–9],
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and former athletes have more lean mass and less fat mass than their sedentary controls in midlife [7].
PA tracks from adolescence to adulthood among women, although only at low to moderate level [10–12]
and organised sport participation in adolescence is associated with healthy lifestyle habits later in
life [13]. Despite these positive effects of PA, some female athletes suffer from conditions such as
low energy availability, eating disorders or disordered eating, menstrual dysfunction and low bone
mineral density (BMD), which can have adverse long-term health effects [14,15]. Further, athletes may
be exposed to injuries, and consequently to later life pain and/or disabilities [16–19], but data on the
prevalence of musculoskeletal problems in former female athletes compared to the general population
is limited. There is also a lack of knowledge regarding fractures in former female athletes compared to
non-athletes [20].
In addition to sport participation in adolescence, age at menarche (AAM) has been shown to be
associated with bone health. AAM is associated negatively with BMD [21–24] and positively with
fracture risk later in life [25,26]. Although female athletes tend to attain menarche later than their
non-athletic peers [27–29], investigating the association between AAM and bone health in adulthood
rarely take into account adolescence PA. Moreover, while there is evidence that AAM is inversely
associated with fat percentage and BMI in adulthood [30–32], it is not known if AAM is associated
with lean mass and physical performance in midlife.
Since, to our knowledge, no previous study has investigated long-term consequences of both
sport participation in adolescence and AAM on midlife characteristics, further information on these
links would provide important information for understanding these relationships. Thus, with this
retrospective descriptive study, we aimed to investigate the associations between competitive sport
participation in adolescence (i.e., at age 13–16) and AAM with middle-aged body composition, BMD,
physical performance, and PA in 47–55-year-old women. Furthermore, we investigated if the lifetime
occurrence of fractures, current musculoskeletal problems, and the lifetime occurrence of anorexia
nervosa differed until middle age according to adolescent physical activity status or AAM.
2. Materials and Methods
2.1. Participants
In the current study, data collected in the Estrogenic Regulation of Muscle Apoptosis (ERMA)
study [33] were utilised. A written invitation was sent to 6878 women representing a random sample
of 47–55-year-old women living in Jyväskylä or neighbouring municipalities in Central Finland.
The response rate was 47%. From the eligible participants (n = 1627), 1393 gave blood samples and
1102 of them provided full questionnaire data. Due to technical error, four questionnaires were lost.
Thus, the sample size of the present study was 1098. Of the whole sample, 988 provided information
about their physical activity (PA) level at age 13–16 and 1081 responded to the question regarding age
at menarche (AAM) (Figure 1).
In the ERMA study, the exclusion criteria were conditions and use of medications affecting
ovarian function, obesity (self-reported BMI > 35 kg/m2), or conditions hindering daily physical or
mental functioning.
The study was approved by the Ethics Committee of the Central Finland Health Care District
(K-S shp Dnro 8U/2014) and all the participants provided written informed consent. The study protocol




Participants described their PA level at age 13–16 as one of four possible options: no exercise, regular
independent leisure-time PA, regular other supervised PA in a sport club etc., and regular competitive
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sport and training related to that sport (modified by Hirvensalo et al. [34]). Regular independent
leisure-time PA was defined as regular PA during a journey to or from school/work (>2 km/one way)
or as regular PA causing sweating that is not organised by a school, sports club, fitness centre, etc.
Did not consent for phase 2 N=445
Do not fill inclusion criteria N=992
Phase 2: Invitation to first laboratory visit 
(N=1627)
ERMA study: 47-55-yr-old women’s cohort
N=6878 (82% of the age-cohort)
Phase 1: Prequestionnaires (N=3064)
Not responding N=3649
Respondents N=3229 (46.9%)
Not willing N=165 
Phase 2: Participated in first laboratory visit with 






Final sample size N=1098
Phase 3: Invitation to questionnaire survey and to 































Provided questionnaire survey (N=1102)
Questionnaires lost due to technical 
error N=4
Figure 1. Flow chart of the recruitment of the participants. BMI = body mass index; DXA = Dual-energy
X-ray absorptiometry; HG = hand grip force; KE = knee extension force; JH = jumping height;
WS = walking speed; WD = walking distance; accelerom. PA = accelerometer-measured physical
activity; self-rep. PA = self-reported physical activity. Some of the participants were excluded for some
or all physical performance tests for the health reasons.
The definition for supervised PA was as follows: all regular non-competitive PA, organised by
a sports club, fitness centre, Girl Scouts, etc. Competitive sport and related training was defined as
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regular, goal-oriented competitive sport within a sports club etc., and competing and training in
that discipline.
Participants were classified into three groups based on their answers: no exercise group, regular
PA group, which includes participants who reported performing independent or supervised or both but
did not report being competing in any sport, and competitive sport group. Participants were also asked
what sports disciplines they were engaged in and they were instructed to underline the disciplines
in which they competed. PA level at other age stages 7–12, 17–19, 20–29, 30–39, and 40–50 years was
similarly assessed to show the tracking of PA.
AAM
Participants self-reported the age of their first menstruation (age at menarche; AAM) and were
subsequently categorised in approximately equal groups as follows: ≤12 years, 13 years, and ≥14 years.
2.2.2. Middle Age Characteristics
Anthropometrics and Body Composition
All of the anthropometrics and body composition measurements were assessed between 7:00 and
10:00 a.m. after overnight fasting. Participants’ weight was measured in their underwear to the nearest
0.01 kg with a beam scale. Height was measured to the nearest 1.0 cm with a stadiometer. BMI was
calculated as weight in kilograms divided by height in meters squared. Femoral neck BMD and body
composition were assessed by dual x-ray absorptiometry (DXA, LUNAR; GE Healthcare, Chicago, IL,
USA) [35]. Fat percentage was calculated as total fat mass divided by total mass multiplied by 100.
Fat and lean mass indexes were calculated as fat mass (kg) and lean mass (kg), respectively, divided by
height squared (m2). Appendicular lean mass index (ALMI) was calculated as arms lean mass (kg)
plus legs lean mass (kg) divided by height squared (m2).
Physical Performance Tests
Muscle performance measurements were performed as presented earlier in Bondarev et al. 2018 [36].
Briefly, hand grip force was assessed on the dominant arm in a sitting position with the elbow flexed
at 90◦ angle using an adjustable dynamometer chair (Good Strength, Metitur, Jyväskylä, Finland).
Participants were instructed to squeeze the handle as forcefully as possible and maintain the contraction
for 2–3 s. Maximal isometric knee extension force was measured in a sitting position, knee fixed in
60 degrees of flexion, on a custom-made dynamometer chair (Good Strength; Metitur Oy, Palokka,
Finland) from the side of the dominant hand. Participants were instructed to extend the knee towards
full extension to produce maximal force. In both the abovementioned tests, the trunk was stabilized
to exclude the compensation of other muscles. Lower body muscle power was assessed with a
countermovement jump performed on a custom-made contact mat. Flight time (t) was recorded and
vertical jumping height (cm) was calculated as (g × t2) / 8 × 100, where g is the acceleration of gravity
(9.81 m/s2) [37]. In all of the three aforementioned muscle force and power tests, three to five maximal
efforts were performed, and the highest value was recorded.
Walking speed was assessed via a 10-m walk in a laboratory corridor using photocells, with five
meters allowed for acceleration prior to measurement [38]. Participants performed two trials with the
fastest accepted as their final result. The 6-min walking test was performed on a 20-m indoor track
and the participants were instructed to walk as many laps as possible in 6 min. This test was used to
assess submaximal exercise tolerance and aerobic capacity [39]. The rest between the different physical
performance tests and between repetitions were separated by an approximately one-minute pause.
The same protocol was applied in every participant (i.e., the instructions for the second tests were
given in the similar way) resulting in approximately similar time between the tests in each participant.
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Accelerometer-Measured PA
Accelerometer-measured PA was assessed using GT3X+ and wGT3X+ accelerometers (ActiGraph,
Pensacola, FL, USA) [40]. Participants were instructed to wear the accelerometer on their right hip
during waking hours (excluding activities in water) for seven consecutive days. Each participant was
personally individually instructed regarding the use of the accelerometer and was also provided with
a diary accompanied with the instructions to record their wake-up time, working hours, and periods
when the accelerometer was removed for over 30 min. Raw acceleration data were collected at 60 Hz
and consequently filtered and converted into 60 s epoch counts. Further data analysis was conducted
with Excel-based customised program. Tri-axial vector magnitude cut-off -points of moderate and
vigorous physical activity were >2690 to ≤6166 cpm and >6166 cpm, respectively [40,41]. The mean times
spent in moderate and vigorous activity per day were summed to obtain the total mean time spent in
moderate-to-vigorous physical activity (MVPA) per day. The mean daily step count was also documented.
Self-Reported PA
Self-reported PA was inquired using a series of modified structured questions [33,42]. Recently,
this tool has been compared with accelerometer-based data in this same cohort and has found to
demonstrate similar association between accelerometer-measured PA compared to other widely used
self-reported PA questionnaires [43]. Participants were asked about their leisure physical activity,
including monthly frequency, mean duration, and mean intensity of PA sessions; and PA during the
journey to and from work. Volume of activity was calculated using an activity metabolic equivalent
(MET) index by assigning a multiple of resting metabolic rate (MET score) to each activity and
calculating the product of intensity × duration × frequency of activity [42].
The following MET values were used (work metabolic rate divided by resting metabolic rate):
4 (for exercise intensity corresponding to walking and for physical activity during the work journey),
6 (vigorous walking to jogging), 10 (jogging), and 13 (running) [44]. The activity MET index was
expressed as the score of leisure MET hours per day and has been validated by Waller et al. [45].
Background Variables
Participants reported their level of education by choosing from eight answer options of primary
school to doctoral level. Participants were classified into two groups based on their answers: those with
bachelor level or higher education and those with education lower than bachelor level.
Participants also reported their number of live births, if they had ever used oral contraceptive pills
and in what year they had started and finished using them. Participants also reported use of hormonal
contraceptives (HC) during the preceding 10 years.
The menopausal status determination procedure followed the Stages of Reproductive Aging
Workshop +10 guidelines [46]. Participants kept a menstrual diary for 6–12 months for menstrual cycle
assessment. Serum samples to measure FSH concentrations were obtained during menstrual days
1–5 for all women who had detectable menstrual bleeding at the onset of study. For participants who
had undergone hysterectomy or were using progesterone-containing contraceptives, the menopausal
group assignment was based solely on the FSH level, but with stricter cut-off values than used for
participants with natural menstrual bleeding [33].
Participants were also asked if they have had one or more fractures in their wrist or forearm, tibia,
femur, or at some other location. Participants were also questioned if they had some musculoskeletal
disorders or symptoms. Additionally, participants were asked to report if they had ever had a diagnosis
of anorexia nervosa and in which year the diagnosis was given.
2.3. Statistical Analysis
All the continuous variables were tested for normality prior to statistical analysis. Continuous
variables are presented as means and 95% confidence intervals, and categorical variables as frequencies
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and percentages. Differences between groups were investigated using one-way analysis of variance
(ANOVA) with Bonferroni post hoc pairwise comparisons or Kruskal-Wallis rank sum test with
subsequent pairwise comparisons for continuous variables, and Pearson’s chi-square for categorical
variables. Analysis of covariance (ANCOVA) was used to adjust for potential confounding factors
(self-reported leisure-time PA in adolescence and in midlife, age, AAM, menopausal status, number of
parities, education, and HC use during the 10 preceding years). As we assumed that BMD in
postmenopausal women regardless of AAM may be lower than in women within the other menopausal
status groups, and therefore potentially skew results or cloud an association between AAM and BMD,
we investigated the association between AAM and BMD also in pre-, early perimenopausal, and late
perimenopausal women only. Statistical analyses were conducted using IBM SPSS Statistics version 24
(Armonk, NY, USA). The significance level was set at <0.05, two-tailed.
3. Results
3.1. PA Participation from Childhood to Midlife
The most common sport disciplines (during 1970s and 1980s) in the competitive sport group
were track and field (28.7%), volleyball (20.6%), cross-country skiing (18.4%), running (16.9%),
Finnish baseball (7.4%), and gymnastics (7.4%). Most of the participants who engaged in competitive
sport at age 13–16 reported having competed in two or more sport disciplines (n = 98, 72.1%).
For each age stage, PA level was compared to the individual’s PA level at age 13–16 years
(i.e., adolescence). At every age stage except the latest (i.e., age 40–50 years), those who engaged
in competitive sport at age 13–16 years formed the larger proportion of those in competitive sport
compared to those that reported regular PA or no exercise at age 13–16 years (p for all <0.001).
Conversely, those who engaged in competitive sport at age 13–16 years formed the smaller proportion
of those with no exercise at all at other age stages except the latest compared to those that reported
regular PA or no exercise at age 13–16 years (p for all <0.001). There was no difference in the PA level
groups between ages 13–16 and 40–50 (p = 0.272) (Table 1). The proportion of the participants engaged
in competitive sport was highest at age 13–16 and gradually decreased thenceforth. Furthermore,
the proportion of those reporting regular PA increased at each age stage after the age of 13–16 (Figure S1).
The correlation coefficients between PA level at age 13–16 and PA level at ages 7–12, 17–19, 20–29,
30–39, and 40–50 were 0.54, 0.60, 0.29, 0.19 (p < 0.001 for all), and −0.02 (p = 0.463), respectively.
Table 1. Proportion (n) of participants of different physical activity (PA) level at each age stages
according to the PA level at the age of 13–16.
Competitive Sport (CS) Regular PA (RPA) No Exercise (NE)
at Age 13–16 (n = 136) at Age 13–16 (n = 689) at Age 13–16 (n = 163)






















































































3.2. Midlife Characteristics According to Adolescence PA
Those who were engaged in competitive sport at age 13–16 were slightly younger and had used
HC more often during the preceding 10 years than participants in the other two groups. Participants
in the competitive sport group also had a higher education level in midlife and later AAM than
participants with no exercise (Table 2).
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Table 2. Midlife characteristics of participants according to physical activity (PA) level at the age of 13–16.




Age (y) 136 50.9 (50.5–51.2) R,N 689 51.4 (51.3–51.6) 163 51.6 (51.3–51.9) 0.005 e
Age at menarche (y) 134 677 162 0.010
≤12 35.1% (47) N 35.2% (238) N 38.9% (63)
13 30.6% (41) 34.3% (232) 43.2% (70)
≥14 34.3% (46) 30.6% (207) 17.9% (29)
Bachelor or higher education 136 48.5% (66) N 689 41.5% (286) 163 34.4% (56) 0.045
Number of parities 136 2.0 (1.8–2.1) 687 2.1 (2.0–2.2) N 163 1.9 (1.7–2.1) 0.017 f
Used OCP at some point of life 136 6.6% (9) 689 9.9% (68) 163 11.0% (18) 0.399
Used HC during the preceding
10 years 136 62.5% (85)
R,N 689 50.8% (350) 163 49.1% (80) 0.031
Menopausal status 136 689 161 0.893
PRE 30.1% (41) 27.4% (189) 24.5% (40)
EPM 19.1% (26) 18.6% (128 19.0% (31)
LPM LPM 21.3% (29) 19.3% (133) 20.9% (34)
POST POST 29.4% (40) 34.7% (239) 35.6% (58)
Body composition
Height (cm) 113 166.4 (165.4–167.4) 609 165.6 (165.1–166.0) 146 164.7 (163.8–165.7) 0.074 e 0.188 a 0.257 c
Weight (m) 113 70.3 (68.3–72.3) 609 70.3 (69.4–71.2) 146 68.5 (66.8–70.1) 0.182 e 0.046 a 0.038 c
BMI (kg/m2) 113 25.4 (24.7–26.1) 609 25.6 (25.3–25.9) 146 25.2 (24.7–25.8) 0.431 e 0.151 a 0.124 c
Total fat mass (kg) 101 24.0 (22.4–25.5) 584 25.5 (24.8–26.2) 138 24.4 (23.1–25.7) 0.141 e 0.041 a 0.037 c
Fat percentage (%) 101 33.3 (31.8–34.7) R 584 35.4 (34.8–36.0) 138 35.0 (33.8–36.2) 0.028 e 0.022 a 0.026 c
Fat mass index (kg/m2) 101 8.7 (8.1–9.3) 584 9.3 (9.0–9.5) 138 9.0 (8.5–9.7) 0.143 e 0.065 a 0.062 c
Total lean mass (kg) 101 43.7 (42.8–44.6) R,N 584 42.1 (41.7–42.4) 138 41.4 (40.7–42.1) <0.001 e 0.001 a 0.001 c
Lean mass index (kg/m2) 101 15.8 (15.5–16.0) R,N 584 15.3 (15.2–15.4) 138 15.2 (15.0–15.5) 0.002 e 0.002 a 0.001 c
ALMI (kg/m2) 101 6.9 (6.7–7.0) R,N 584 6.6 (6.6–6.7) 138 6.6 (6.5–6.7) <0.001 e 0.001 a 0.001 c
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Table 2. Cont.




FN BMD (g/cm2) 101 1.00 (0.98–1.03) R,N 584 0.96 (0.95–0.97) 138 0.95 (0.93–0.97) <0.001 e 0.001 a 0.002 c
FN T score < −1 101 14.9% (15) R,N 584 25.7% (150) 138 28.3% (39) 0.039
FN T score ≤ −2.5 101 0.0% (0) 584 0.9% (5) 138 0.7% (1) 1.000
Physical performance
Hand grip force (N) 106 333.5 (322.6–344.4) R,N 590 313.5 (308.7–318.4) 142 305.5 (296.4–314.5) 0.001 e 0.002 a 0.002 c
Knee extension force (N) 92 509.1 (488.4–529.8) R,N 508 460.6 (452.7–468.4) 118 442.3 (425.6–458.9) <0.001 e <0.001 a <0.001 c
Jumping height (cm) 101 21.3 (20.5–22.1) R,N 547 19.0 (18.6–19.3) 136 18.7 (18.0–19.4) <0.001 e <0.001 a <0.001 c
Walking speed (m/s) 106 2.9 (2.8–3.0) R,N 591 2.6 (2.6–2.7) 140 2.6 (2.5–2.6) <0.001 e <0.001 a <0.001 c
Walking distance in 6 min (m) 95 696.7 (684.8–708.5) R,N 543 667.5 (662.3–672.7) 131 660.7 (651.1–670.2) <0.001 e <0.001 a 0.001 c
Self-reported PA
Leisure-time PA (MET-h/d) 136 4.9 (4.2–5.6) R,N 689 4.2 (3.9–4.4) 163 3.6 (3.2–4.0) <0.001 f 0.008 b 0.007 d
Accelerometer-measured PA
Leisure-time MVPA (min/d) 88 47.6 (41.6–53.6) 516 43.1 (41.1–45.2) 126 40.7 (36.6–44.7) 0.166 f 0.178 b 0.271 d
Leisure-time step count (steps/d) 88 7277 (6676–7878) 516 6843 (6601–7084) 126 6763 (6334–7192) 0.339 e 0.302 b 0.384 d
Total MVPA (min/d) 88 54.3 (47.7–60.7) 516 50.3 (48.0–52.5) 126 46.7 (42.6–50.8) 0.188 f 0.220 b 0.312 d
Total step count (steps/d) 88 8903 (8291–9515) 516 8698 (8450–8947) 126 8510 (8087–8933) 0.646 f 0.743 b 0.761 d
Values are presented as means (95% confidence intervals) or percentages (counts). R and N indicate significant difference (p < 0.05) from regular PA and no exercise groups,
respectively. OCP = oral contraceptive pills; HC = hormonal contraceptive; PRE = premenopausal; EPM = early perimenopausal; LPM = late perimenopausal; POST = postmenopausal;
BMI = body mass index; ALMI = appendicular lean mass index; FN = femoral neck; BMD = bone mineral density; MET = metabolic equivalent; MVPA = moderate-to-vigorous physical
activity. a Adjusted for self-reported leisure-time PA in midlife, age, menarcheal age, and menopausal status. b Adjusted for age, menarcheal age, and menopausal status. c Adjusted for
self-reported leisure-time PA in midlife, age, menarcheal age, menopausal status, number of parities, education, and hormonal contraceptive use during the 10 preceding years. d Adjusted
for age, menarcheal age, menopausal status, number of parities, education, and hormonal contraceptive use during the 10 preceding years. e ANOVA. f Kruskal-Wallis test. Sample sizes
for both adjusted models were 111, 598, and 149 for competitive sport, regular PA, and no exercise groups, respectively, in height, weight, and BMI. Corresponding sample sizes for body
composition measurements and BMD were 99, 573, and 137, for physical performance measurements they were 104, 579, and 141 (hand grip force), 90, 500, and 118 (knee extension force),
99, 538, and 135 (jumping height), 104, 580, and 139 (walking speed), 93, 534, and 131 (walking distance in 6 min), and for physical activity measurements they were 134, 677, and 162
(self-reported PA) and 86, 510, and 125 (accelerometer measured PA). Statistically significant p-values are indicated in bold.
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Participants in the competitive sport group had more lean mass, higher lean mass index,
ALMI, and BMD than those with no exercise or regular PA. They also performed better in all
physical performance tests than participants in the other two groups. Self-reported PA at midlife
was higher in the competitive sport group than in the other groups but no difference was found in
accelerometer-measured PA between the groups. Differences in total lean mass, lean mass index,
ALMI, BMD, physical performance, and self-reported leisure-time PA between the competitive sport
group and the other groups remained after adjustment for potential confounding factors (Table 2).
Participants who did not respond to the question regarding PA at age 13–16 (11.1% of the whole sample,
n = 110) were similar to those who completed all variables except in hand grip force (non-responders
297.9 N vs. responders 314.7 N, p = 0.018) and in menopausal status (proportions of premenopausal,
early perimenopausal, late perimenopausal, and postmenopausal among non-responders 30.9%, 11.8%,
11.8%, and 45.5%, respectively and among responders 27.3%, 18.7%, 19.8%, and 34.1%, respectively,
p = 0.018).
3.3. AAM and Midlife Characteristics
AAM among participants ranged between 9 and 19 years (Table S1) with mean age 12.95 years
(95% CI 12.9–13.0). The most common menarcheal ages were 13 (34.9%), 12 (24.1%), and 14 years
(17.8%). 102 (9.3%) of the participants reported that they had used OCP at some point of their life with
starting age between 16–54 years. No participants reported starting OCP use before menarche and 15
of the OCP users did not provide starting year.
The group that reported AAM ≥ 14 years included the smallest portion of participants with no
exercise and the greatest portion of participants with regular PA and competitive sport at age 13–16.
There was a significant linear downward trend in weight, BMI, total fat mass, fat percentage, and fat
mass index across the AAM groups, all of which decreased as AAM increased. All pairwise comparisons
were statistically significant except for fat percentage between the group reporting AAM ≤ 12 years
and the group reporting AAM = 13 years. BMD was higher in the group reporting AAM ≤ 12 years
compared to the group reporting AAM ≥ 14 years and differences in physical performance were found
in jump height, with the group of AAM ≥ 14 years jumping higher than the group of AAM ≤ 12
years. Participants in the group reporting AAM ≥ 14 years took more steps than those in the other
groups, but no other differences in PA between the groups were found. The differences in weight, BMI,
fat mass, fat mass index, ALMI, jump height, and leisure-time step count persisted when adjusted for
confounding factors (Table 3). Exclusion of postmenopausal women from this analysis demonstrated
an inverse association between AAM and BMD even when adjusted for PA level at age of 13–16,
self-reported leisure-time PA at midlife, age, and menopausal status (p = 0.040). The inverse association
was found also after further adding number of parities, education, and hormonal contraceptive use
during the 10 preceding years as covariates in the model (p = 0.041).
16.2% (n = 178) of the participants reported that they have had at least one fracture during their
life, while 37.6% (n = 413) reported having current musculoskeletal disorder/symptom. Six participants
(0.5%) reported that they have received a diagnosis of anorexia nervosa, while one participant did not
answer this question. Age at the time of the diagnosis varied between 13 and 39 (mean 21.5, 95% CI
10.5–32.5) and two participants had received the diagnosis before AAM. No differences were found in
the amount of lifetime fractures and anorexia nervosa prevalence, or current musculoskeletal problems
between the different PA level in adolescence (Table S2) or AAM groups (Table S3). The participants
who did not respond to the question regarding AAM (1.5%, n = 17) were similar to those who did in
terms of all the outcome variables.
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Table 3. Midlife characteristics of the participants according to different menarcheal age.




Age (y) 391 51.3 (51.1–51.5) 377 51.4 (51.2–51.6) 313 51.4 (51.2–51.6) 0.465 e
Bachelor or higher education (%) 391 41.2% (161) 377 41.9% (158) 313 40.9% (128) 0.961
Number of parities 391 2.0 (1.9–2.2) 377 2.0 (1.9–2.1) 313 2.0 (1.9–2.2) 0.937 f
Used OCP at some point of life 391 7.9% (31) H 377 7.7% (29) H 313 13.1% (41) 0.025
Used HC during the preceding
10 years 391 54.2% (212) 377 48.0% (181) 313 53.7% (168) 0.172
Menopausal status 390 377 313 0.373
PRE 24.8% (97) 29.7% (112) 29.4% (92)
EPM 20.2% (79) 17.2% (65) 16.3% (51)
LPM 21.7% (85) 17.2% (65) 18.2% (57)
POST 33.2% (130) 35.8% (135) 36.1% (113)
PA at age 13–16 346 343 281 0.014
CS 13.5% (47) H 12.0% (41) H 16.4% (46)
RPA 68.6% (238) 67.9% (233) 73.3% (206)
NE 17.9% (62) 20.1% (69) 10.3% (29)
Body composition
Height (cm) 335 165.3 (164.7–165.9) 341 165.3 (164.7–166.0) 266 166.3 (165.6–166.9) 0.073 e 0.122 a 0.135 c
Weight (m) 335 71.7 (70.5–72.8) M,H 341 69.6 (68.4–70.7) 266 68.0 (66.8–69.3) <0.001 e <0.001 a <0.001 c
BMI (kg/m2) 335 26.2 (25.8–26.6) M,H 341 25.4 (25.0–25.8) H 266 24.6 (24.2–25.0) <0.001 e <0.001 a <0.001 c
Total fat mass (kg) 315 26.6 (25.7–27.5) M,H 319 24.9 (24.0–25.9) H 247 23.1 (22.0–24.2) <0.001 e <0.001 a <0.001 c
Fat percentage (%) 315 36.4 (35.6–37.1) H 319 35.1 (34.3–35.9) H 247 33.1 (32.1–34.0) <0.001 e <0.001 a <0.001 c
Fat mass index (kg/m2) 315 9.7 (9.4–10.1) M,H 319 9.1 (8.8–9.4) H 247 8.4 (8.0–8.8) <0.001 e <0.001 a <0.001 c
Total lean mass (kg) 315 42.3 (41.8–42.8) 319 41.8 (41.4–42.3) 247 42.3 (41.8–42.9) 0.105 e 0.099 a 0.195 c
Lean mass index (kg/m2) 315 15.5 (15.4–15.6) 319 15.3 (15.2–15.5) 247 15.3 (115.2–15.5) 0.135 e 0.032 a 0.047 c
ALMI (kg/m2) 315 6.7 (6.6–6.7) 319 6.6 (6.5–6.7) 247 6.6 (6.5–6.7) 0.237 e 0.075 a 0.124 c
BMD
FN BMD (g/cm2) 315 0.97 (0.96–0.98) H 319 0.96 (0.95–0.97) 247 0.94 (0.93–0.96) 0.034 e 0.056 a 0.056 c
FN T score < −1 315 24.2% (76) 319 23.5% (75) 247 29.6% (73) 0.214
FN T score ≤ −2.5 315 0.3% (1) 319 1.3% (4) 247 0.8% (2) 0.404
Physical performance
Hand grip force (N) 321 314.0 (307.2–320.8) 324 315.0 (308.6–321.5) 254 311.0 (304.0–318.1) 0.715 e 0.279 a 0.195 c
Knee extension force (N) 282 468.8 (457.7–480.0) 271 457.8 (447.1–468.5) 230 459.7 (446.6–472.7) 0.344 e 0.419 a 0.442 c
Jumping height (cm) 300 18.7 (18.3–19.2) H 302 19.2 (18.7–19.7) 243 19.8 (19.2–20.4) 0.013 e 0.019 a 0.013 c
Walking speed (m/s) 319 2.6 (2.6–2.7) 324 2.7 (2.6–2.7) 255 2.7 (2.6–2.7) 0.443 e 0.508 a 0.507 c
Walking distance in 6 min (m) 300 665.5 (658.5–672.5) 293 669.8 (663.2–676.3) 240 674.1 (666.0–682.1) 0.259 e 0.155 a 0.093 c
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Leisure time PA (MET-h/d) 391 4.4 (4.0–4.8) 377 4.0 (3.6–4.3) 313 4.2 (3.8–4.5) 0.l78 f 0.288 b 0.285 d
Accelerometer-measured PA
Leisure-time MVPA (min/d) 282 42.4 (39.6–45.2) 277 41.0 (38.4–43.6) 225 46.9 (43.4–50.4) 0.054 f 0.053 b 0.036 d
Leisure-time step count (steps/d) 282 6812 (6495–7128) H 277 6586 (6282–6892) H 225 7365 (6986–7744) 0.005 f 0.025 b 0.018 d
Total MVPA (min/d) 282 48.6 (45.6–51.6) 277 48.3 (45.6–51.1) 225 53.6 (49.8–57.5) 0.117 f 0.117 b 0.093 d
Total step count (steps/d) 282 8541 (8214–8868) H 277 8492 (8179–8804) H 225 9066 (8677–9455) 0.030 f 0.166 b 0.169 d
Values are presented as means (95% confidence intervals) or percentages (counts). M and H indicate significant difference (p < 0.05) from the middle and the latest menarcheal
group, respectively. AAM = age at menarche; PRE = premenopausal; EPM = early perimenopausal; LPM = late perimenopausal; POST = postmenopausal; PA = physical activity;
NE = no exercise; RPA = regular physical activity; CS = competitive sport; BMI = body mass index; ALMI = appendicular lean mass index; FN = femoral neck; BMD = bone mineral density;
MET = metabolic equivalent; MVPA = moderate-to-vigorous physical activity. a Adjusted for PA level at age of 13–16, self-reported leisure-time PA in midlife, age, and menopausal status.
b Adjusted for PA level at age 13–16, age, and menopausal status. c Adjusted for PA level at ages 13–16, self-reported leisure-time PA in midlife, age, menopausal status, number of parities,
education, and hormonal contraceptive use during the 10 preceding years. d Adjusted for PA level at age 13–16, age, menopausal status, number of parities, education, and hormonal
contraceptive use during the 10 preceding years. e ANOVA. f Kruskal-Wallis test. Sample sizes for both adjusted models were 299, 312, and 243 for groups reporting AAM ≤ 12 years,
= 13 years, and ≥ 14 years, respectively, in height, weight, and BMI. Corresponding sample sizes for body composition measurements and BMD were 286, 295, and 228, for physical
performance measurements they were 291, 299, and 234 (hand grip force), 252, 246, and 210 (knee extension force), 271, 278, and 223 (jumping height), 289, 299, and 235 (walking speed),
270, 268, and 220 (walking distance in 6 min), and for physical activity measurements they were 348, 343, and 282 (self-reported PA) and 257, 254, and 210 (accelerometer-measured PA).
Statistically significant p-values are indicated in bold.
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4. Discussion
This is the first study to describe midlife body composition, BMD, physical performance, and PA
according to PA in adolescence and AAM in middle-aged women. We found that those who had been
engaged in competitive sport at age 13–16 had more lean mass, higher BMD in the femoral neck,
and better physical fitness in midlife than participants with regular PA or no exercise, even when
adjusted for potential confounding factors. Participants in the competitive sport group had later
AAM than those with no exercise in adolescence. Furthermore, participants with later AAM had
lower BMI and less fat mass than those with earlier AAM, and BMD was lower in the group with
AAM ≥ 14 compared to those with AAM ≤ 12. These associations persisted when adjusted for potential
confounding factors, except for the difference in BMD. However, when postmenopausal participants
were excluded from this analysis, an inverse relationship between AAM and BMD was found regardless
of the confounding factors.
4.1. PA Participation from Childhood to Midlife
We observed declining correlation coefficients between PA level at age 13–16 and PA level at other
age stages with advancing age, which is consistent with a meta-analysis conducted by Craigie et al. [11]
who found that the strength of tracking of PA declined when the duration of the follow-up increased.
In our study, participation in competitive sport in adolescence was associated with higher self-reported
leisure-time PA in middle-age, which is in line with an earlier study showing that participation in
competitive sport in adolescence predicts maintenance of a high PA level in old age [34]. However,
we found no association between PA in adolescence and accelerometer-measured PA in midlife.
We may, however, have lacked sufficient power to detect these differences as the sample sizes were
smaller in accelerometer-measured compared to self-reported PA.
4.2. Association between PA in Adolescence and AAM
Previous studies have stated that adolescent athletes tend to attain menarche later than their less
physically active counterparts [28,29], and similarly in the present study, participants in the competitive
sport group and regular PA group had later AAM compared to the no exercise group. Studies have
shown that although AAM is largely modified by genes [47–49], it is influenced by environmental
factors, including PA [50]. However, since evidence regarding an association between PA before
menarche and later AAM is limited [28], it is not known if there is a causal relationship between
these variables, if selection bias was present or if other behavioural differences between athletes and
non-athletes explain the reported association [27,28].
4.3. Competitive Sport in Adolescence and Midlife Characteristics
We found no difference in fat mass between the adolescent PA groups, in contrast lower fat mass
in former gymnasts, runners, and swimmers compared to controls in midlife has been reported [7,9].
The inconsistency between the studies may be due to different study population, with aesthetic and
endurance athletes tending to have lower BMI than athletes in other sport disciplines [27], with our
study representing a variety of sporting disciplines. Furthermore, our finding concerning higher
midlife lean mass in participants in the competitive sports group is in agreement with one [7] but in
contrast to another [9] study.
Consistent with some [7,9] but not all studies [51], we found that there was an association between
competitive sport in adolescence and higher BMD in midlife. In our study, this association persisted
after adjusting for potential confounding factors. This is contrary to the findings of Nilsson et al. [52],
who reported that among women aged 75–80 years PA at age 10–30 was positively associated with
BMD, but this association was not seen when adjusted for current PA. Therefore, in older women,
current PA might be more strongly associated with BMD than PA in adolescence [53]. Further, and again
in contrast to our findings, these authors found no association between PA at age 10–30 and current
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hand grip strength among women aged 75–80 [52]. These inconsistencies may be due to the fact that
participants in our study were younger and PA history was studied in narrower age-range than in the
study conducted by Nilsson and colleagues.
While it has been found that the risk of osteoarthritis of the hip and knee is greater in former female
athletes compared to the general population [54] and that former athletes have higher risk of knee
problems and higher rates of Achilles tendon problems in later life compared to controls [55], we did
not find an association between sport participation in adolescence and musculoskeletal problems in
middle age. As we did not ask participants what kind of musculoskeletal problems they had, it is
possible that in our study, specific types of problems were more common in different groups.
In contrast to our findings, Tveit et al. found that a risk of fracture was lower among former male
athletes than among controls [56]. However, we did not differentiate fractures occurred during the
sport career from those occurred after retirement from sport. In addition to the fact that participants
in the study conducted by Tveit et al. [56] were males, they were also older than those in our study.
The incidence of fractures has been reported to be higher among older women compared to our study
population [57,58] and thus, fracture rates among women in our study were relatively low.
Due to low number of anorexia nervosa cases in our study, no conclusion in terms of possible
association between anorexia and PA in adolescence can be made. Other studies have suggested that
eating disorders in general are more common in athletes than in non-athletes [59,60]. The lifetime
prevalence of anorexia nervosa in our study was lower than recently found among middle aged women
living in UK [61], young adult women living in Finland [62], and also slightly lower than in women
living in U.S. [63]. Incidence of eating disorders are highest in adolescence and in young adulthood [64],
and our participants were at that age in 1970s and 1980s. It has been reported that anorexia nervosa
has become more common since that time [65], which may explain the differences between the results
of abovementioned studies and our findings. However, it is suggested that the increased prevalence
rates may be due to increased detection of anorexia nervosa rather than true increase of incidence
rates [65]. Thus, there might have been some undiagnosed anorexia nervosa cases among our study
population as well. Furthermore, in our study, diagnosis of anorexia nervosa was self-reported and
asked by a single question, which may further underestimate the actual prevalence rate.
4.4. AAM and Midlife Characteristics
In line with previous observational evidence [31,32,66–73], our results show that AAM is inversely
associated with BMI, fat mass, and fat percentage in middle-age. The inverse relationship between AAM
and BMI in adulthood was also recently supported by Mendelian randomisation studies [48,74,75].
Fewer studies have investigated the association between AAM and midlife lean mass. Similar to our
finding, Kirchengast et al. [66] did not find an association between AAM and lean mass either in pre-
or postmenopausal women.
The observed inverse relationship between AAM and midlife BMD in the current study is
consistent with findings of some studies conducted in women with a mean age over 40 years [21,76]
and also in postmenopausal women only [22,24,77]. However, not all studies have found this
association [78–84] and also in our study, the relationship was abolished after adjusting models
for potential confounding factors. While shared genetic factors have shown to influence both AAM
and BMD [76,85,86], postmenopausal bone loss may interfere with this relationship; the association
between early menarche and higher BMD may be stronger in premenopausal than in postmenopausal
women [85]. Our finding showing a relationship, regardless of confounding factors but excluding
postmenopausal women, between AAM and midlife femoral neck BMD in pre- and perimenopausal
supports this hypothesis. However, higher body mass is known to associate with higher BMD [87,88],
which also may affect the associations between AAM and BMD that were found in our study. Therefore,
further studies are needed to clarify the effects of AAM on midlife BMD. In our study population,
there were few participants with extremely late AAM (e.g., >16 years) and thus, there was no statistical
power to compare that group with earlier AAM. Thus, more research is needed to investigate if there is
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even greater difference in midlife BMD between former athletes with the current criterion of primary
amenorrhea (i.e., menarche occurred at the age of 15 or older) and those with AAM < 15 years.
In contrast to our findings, late AAM has been linked to increased fracture risk in later life [26,89–92].
A possible explanation for the controversy between earlier studies compared to ours may be that in our
study participants were younger than those in the studies demonstrating this association. Furthermore,
again in contrast to our findings, it has been suggested that early menarche is associated with chronic
widespread musculoskeletal complaints in later life [93]. No conclusion regarding the association
between anorexia nervosa and AAM can be made based on the current study due to only few anorexia
nervosa cases in our study population. However, in several other studies anorexia nervosa has been
linked to later menarche [94].
4.5. Limitations
We acknowledge some limitations. PA level in adolescence and AAM were self-reported
retrospectively and thus susceptible to response or recall bias. It is reasonable to assume that those who
had been competitive athletes in their adolescence did not have difficulties in assigning themselves in
an accurate PA category. However, differentiation between no exercise and regular PA may have been
overlapping with the possibility that participants had different perceptions for PA. In addition, it has
been reported that long-term recall of AAM is fairly valid [95–98] and that the accuracy of recall is
increased when AAM is categorised into groups [98]. We did not ask the precise month the participant
attained menarche, which may have caused some inaccuracy; however, few middle-aged women are
able to recall the precise month they started to menstruate [96,97]. Furthermore, the study design does
not enable causal interpretations. Although we adjusted our analysis for potential confounding factors,
residual confounding cannot be completely ruled out. It is possible that other factors, such as genetic
or different lifestyle habits, affected the observed associations.
No information on menstrual history, such as history of menstrual dysfunction, was collected
and thus, we do not know if the participants have had regular menses after menarche. On the other
hand, recall of menstrual regularity is less accurate than recall of AAM in women near menopause [95].
In addition, we did not collect information on training volume in adolescence and thus, cannot be
sure if the participants engaged in competitive sport in adolescence actually differed from those
who exercised regularly in terms of training volume and intensity. Furthermore, our study sample
consisted of Caucasian relatively healthy individuals with no health conditions jeopardizing physical
or mental conditioning, which can limit the generalisability of the results. Finally, the sample size
did not allow us to investigate interaction affects between AAM and sport participation on BMD and
body composition. However, it is possible that such interactions exist. Thus, based on our results,
we cannot say if, for example, individuals who participated in competitive sport during adolescence
but had an AAM ≤ 12 years have better midlife BMD than those in a competitive sport group with an
AAM ≥ 14 years.
It is also important to bear in mind that our participants engaged in competitive sport in their
adolescence, approximately 40 years ago. Since then, sport specialisation at early age has increased
globally [99] and participation in organised sport club has become more frequent in Finnish girls [100].
Early sport specialisation can lead to physical and mental harm as it has been linked to reduced motor
skill development, increased injury rates, sport dropout, burnout, eating disorders, and menstrual
dysfunction [99,101–103]. Thus, generalisability of our results to those who are currently engaged in
competitive sport should be done with caution.
5. Conclusions
This large, retrospective study suggests that participation in competitive sport at age 13–16 is
associated with higher midlife lean mass and femoral neck BMD, and better physical performance
compared to regular PA or no exercise during adolescence. In addition, we found that competitive
sport at age 13–16 was associated with later menarche compared to no exercise at that age. The current
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study also showed that AAM was negatively associated with midlife BMI and fat mass regardless
of confounding factors in all participants, and with femoral neck BMD in pre- and perimenopausal
women. Thus, competitive sport in adolescence seems to be associated with healthier body composition,
higher BMD, and better performance in midlife, but late AAM might be associated with low BMD.
Further research is needed to investigate whether middle-aged or older individuals with primary
amenorrhea (i.e., AAM ≥ 15 years) differ from individual with AAM < 15 years especially in terms of
BMD or fractures. Furthermore, future studies should investigate what is the volume and intensity of
the exercise needed in adolescence with respect to positive outcomes in middle age seen in our study.
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